Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Conclusion: Retatrutide Safety Outlook Retatrutide continues to generate interest as a potential future option for weight management, but its complete safety profile is still being established through ongoing research
patients and clinicians should refer to the current NICE topic page for the up-to-date appraisal status of tirzepatide for weight management, as this may change over time
Rates of major abdominal surgery were similar between groups, with no signal of increased surgical risk
Brain-boosting antioxidant enhancing energy, clarity, and cellular detox
Stahl quote: "Follow the FDA label and never get anybody better" [22:10] When GLP-1s aren't appropriate [24:01] Case study: patient on paliperidone gaining weight despite tirzepatide [25:52] Discovery of nucleus tractus solitaris [28:26] The "are we allowed to prescribe this?" debate [29:10] Valproic acid, propranolol, and scope of practice [30:01] Bipolar disorder, obesity, and mood episode frequency [30:49] Moving beyond the monoamine hypothesis [31:19] UK paper: no proof depression is serotonin deficiency [33:23] Alternative treatments: TMS, ketamine, GLP-1s [34:03] Dr
